Study of the etiology and associated risk factors in a sample of 300 patients with atrial fibrillation;Estudio de la etiología y factores de riesgo asociados en una muestra de 300 pacientes con fibrilación auricular

Revista Espanola de Cardiologia

Volumn 52, Issue 6, 1999, Pages 403-414

  Álvarez, Vicente Barriales ^a   De la Tassa, César Morís ^a   Posada, Ignacio Sánchez ^a   Villa, Roberto Barriales ^a   López, José Rubín ^a   De la Hera Galarza, Jesús M ^a   Manso, Javier Vara ^a   Nava, Sergio Hevia ^a   Llosa, Arturo Cortina ^a  

^a NONE

Author keywords

Armythmia; Atrial fibrilation; Cerebral infarction; Risk factors

Indexed keywords

AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; MIDDLE AGED; RISK FACTOR;

AGED; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0033146689     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(99)74938-9     Document Type: Article

References (56)

1. Lewis T. Auricular fibrillation: a common clinical condition. Br Med J 1909; 2: 1.528-1.533.
2. Phillips SJ, Whismnant J, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes in residentss of Rochester. Minnesota. Mayo Clin Proc 1990; 65: 344-359.
3. Campbell A, Caird FI, Jackson TFM. Prevalence of abnormalities of electrocardiogram in old people. Br Heart J 1974; 36: 1.005-1.011.
4. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju RM. Prevalence of atrial fibrillation in elderly subjetcs: the Cardiovascular Health Study. Am J Cardiol 1994; 74: 238-241.
5. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factors for stroke: the Framinghan Study. Stroke 1991; 22: 983-988.
6. Kitchin AH, Milne JS. Longitudinal survey of ischaemic disease in a randomly selected sample of older population. Br Heart J 1977; 39: 889-893.
7. Benjamin EM, Levy D, Varizi S, Blanger AJ, D'Agostino RB, Kannel WB. Precursors of atrial fibrillation in a population-based cohort: The Framinghan study. Circulation 1993; 87: 698.
8. Kannel WB, Abbott RD, Savage MD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. N Engl J Med 1982; 306: 1.018-1.022
9. Benjamin EJ, Levy D, VAziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framinghan Heart Study. JAMA 1994; 271: 840-844.
10. Lévy S. Épidémiologie et nosologie de la fibrillation auriculaire. Arch Mal Coeur 1994; 87: 11-15.
11. Janse MJ. Why does atrial fibrillation occur? Eur Heart J 1997; 18 (Supl C): 12-18.
12. Rodríguez Suarez ML, Martínez Trabanco JI, Rodríguez Llorián AC, Cortina Llosa A. Fibrilación auricular en la práctica médica. Aten Primaria 1996; 18: 458-464.
13. Ozdemir M, Goksel S, Kuralt T, Erdogan A, Diker E, Aydogdu S et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol 1996; 77: 96-98.
14. Berjón Reyero J, Olaiz Preciado F. De los Arcos Lage E. Epidemiología, factores de riesgo y patogenia de la fibrilación auricular y del flutter auricular. Rev Esp Cardiol 1996; 49 (Supl 2): 1-7.
15. Daniel González H, Palacios Martínez J, Sanagustín MT, Hernández Hernández F, Castellanos E, García-Cosío F. Epidemiología y clínica de la fibrilación auricular. Monocardio 1996; 42: 18-24.
16. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease in atrial fibrillation: the Framinghan Study. Am Heart J 1983; 106: 389-396.
17. Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS. Prevalence and significance af atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol 1988; 61: 714-717.
18. Kitchin AH, Milne JS. Longitudinal survey of ischemic heart disease in randomly slected sample of older population. Br Heart J 1977; 39: 889-895.
19. Myburgh DP, Ker JA. Heart failure in a hospitalised population. Cardiovasc J South Afr 1995; 6: 137-141.
20. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framinghan Study. JAMA 1985; 254: 3.449-3.453.
21. Krahn AD, Manfreda J, Tate RB, Mathewson FAL, Cuddy T. The natural history of atrial fibrillation: incidence, risk factors and prognosis in the Manitoba Follow-Up Study. Am J Med 1995; 98: 476-484.
22. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographics predictors of nonrheumatic atrial fibrillation. The Framinghan Heart Study. Circulation 1994; 89: 724-730.
23. Diker E, Aydogdu S, Ozdemir M, kural T, Polak K, Cehreli S et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol 1996; 77: 96-98.
24. Lacroix D, Lekieffre J, Kacet S, Klug D. Thromboembolic complications of atrial fibrillation. Arch Mal Coeur Vaiss 1994; 87: 17-23.
25. Cerebral Embolism Task Force. Cardiogenic brain embolism: the second report of the cerebral embolism task force. Arch Neurol 1989; 46: 727-743.
26. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized trials. Arch Intern Med 1994; 154: 1.449-1.457.
27. Gershlick AH. Anticoagulation and atrial fibrillation in rheumatic and non-rheumatic heart disease. Vessels 1996; 2: 4-11.
28. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obteined by unipolar precordial and limb leads. Am Heart J 1949; 37: 161-186.
29. Vara J, Reguero JR, Lambert JLR, Segovia E, Arias JC, Álvarez G et al. Prevalence and aetiology of atrial fibrillation. Prospective candidates for anticoagulation therapy. Eur Heart J 1997; 18: 215.
30. Delahaye JP, Milon H, Boissonat P. La fibrillation auriculaire: quelques problèmes pratiques actuels. Ann Cardiol Angeiol 1986: 35: 597-606.
31. Halpern JL, Hart RG. Atrial fibrillation and stroke: new ideas, persiting dilemmas. Stroke 1988; 19: 937-941.
32. Capucci A, Villani GQ, Aschieri D. Risk of complications of atrial fibrillation. PACE 1997; 20: 2.684-2.691.
33. Davidson E, Weinberger I, Rotenberg Z, Fuchs J, Agmon J. Atrial Fibrillation. Arch Intern Med 1989; 149: 457-459.
34. Levy S. Factors predisposing to the development of atrial fibrillation. PACE 1997; 20 (parte 2): 2.670-2.674.
35. Haissaguerre M, Bonnet J, Billes MA. Prevalence, signification et pronostic des arrythmies auriculaires dans les myocardiopathies dilatées. À propos de 236 cas. Arch Mal Coeur 1985; 4: 536-541.
36. Sakamoto H, Okamoto E, Imataka K, Ieki K, Fujui J. Prediction of early development of chronic nonrheumatic atrial fibrillation. Jpn Heart J 1995; 36: 191-199.
37. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2.455-2.461.
38. Selzer A. Atrial fibrillation revisited. N Engl J Med 1982; 306: 1.044-1.045.
39. Baily GWH, Braniff BA, Hancock EW, Cohn KE. Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. Ann Intern Med 1968; 69: 13-20.
40. Thomas F, Morcet JF, Benetos A. Guize L. Cardiovascular mortality in patients with atrial fibrillation. Eur Heart J 1997; 18: 215.
41. Barriales V, Rodríguez VM, Morís C, Möller I, Barriales I, Lambert JLR et al. Risk factors and heart disease in patients with arterial hypertension. Rev Lat Cardiol 1995; 16: 214-217.
42. Casale PN, Devereux RB, Milner M, Hammond IW. Value of echocardiographic measurement of left ventricualr mass in predicting cardiovascular morbid events in hypertensive man. Ann Intern Med 1986; 105: 173-178.
43. Cohen EJ, Klatsky AL, Armstrong MA. Alcohol use and supraventricular arrhytmia. Am J Cardiol 1988; 62: 971-973.
44. Ettinger PO, Wu CF, De la Cruz JR. Haider B, Regan TJ, Lyons M et al. Arrhytmias and the «holiday heart»: alcohol-associated cardiac rhythm disorders. Am Heart J 1978; 95: 555-559.
45. Koskinen P, Kupari M, Leinonen H. Alcohol and new onset of atrial fibrillation: a case-control study of a current series. Br Heart J 1987; 57: 473-476.
46. Koskinen P, Kupari M, Leinonen H. Role of alcohol in recurrences of atrial fibrillation in persons < 65 years of age. Am J Cardiol 1990; 69: 954-958.
47. Batalla A, Barriales V, Morís C, Rodríguez VM, Möller I, Barriales R et al. Factores de riesgo coronario y presencia de cardiopatía en varones consumidores de alcohol. Clin Inv Arteriös 1994; 6 (Supl 1): 38.
48. Cobler JL, Williams ME, Greeland P. Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation. Arch Intern Med 1984; 144: 1.758-1.760.
49. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1.249-1.252.
50. Kopecky SL, Gersch BJ, Phill D, Crosby LH, Rials SJ, Marinchak RA et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987; 317: 669-674.
51. Wolf PA, Dawber TR, Thomas HE, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framinghan study. Neurology 1978; 28: 973-977.
52. Lapaucis A, Albers G, Dalen J, Dunn M, Feinberg W. Jacobson A. Antithrombotic therapy in atrial fibrillation. Chest 1995; 108 (Supl): 352-359.
53. Wolf PA. Benjamín EJ, Belanger AJ, Kanne WB, Laey D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: the Framinghan Study. Am Heart J 1996; 131: 790-795.
54. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 1992; 116: 6-12.
55. Kamensky G, Drahos P, Plevová N. Left atrial sponteneous echo contrast: its prevalence and importance in patients undergoing transesophageal echocardiography and particularly those with a cerebrovascular embolie event. J Am Soc Echocardiog 1996; 9: 62-70.
56. Kamensky G, Drahos P, Plevová N. Evaluación del riesgo embólico en pacientes con fibrilación auricular utilizando ecocardiografía transesofágica. Cardiovascular 1998; 19: 49-54.